Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095

Karin Söderkvist, Maira Zia, Adalsteinn Gunnlaugsson, Andreas Josefsson, Bjørg Aksnessæther, Chunde Li, Camilla Thellenberg-Karlsson, Daniel Alm, David Kudrén, Erik Lundin, Gabriel Moise, Jenny Kahlmeter Brandell, Jon Kindblom, Kirsten Björnlinger, Kristin Karlsson, Katrine Riklund, Martina Westin, Mattias Hedman, Natalie Skorve, Pernilla Wikström, Sara Strandberg, Joakim Jonsson

Open source

DOI: 10.1186/s12885-026-15906-6
Published: 2026-03-25
Container: BMC Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-15906-6,
  title = {Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095},
  author = {Karin Söderkvist and Maira Zia and Adalsteinn Gunnlaugsson and Andreas Josefsson and Bjørg Aksnessæther and Chunde Li and Camilla Thellenberg-Karlsson and Daniel Alm and David Kudrén and Erik Lundin and Gabriel Moise and Jenny Kahlmeter Brandell and Jon Kindblom and Kirsten Björnlinger and Kristin Karlsson and Katrine Riklund and Martina Westin and Mattias Hedman and Natalie Skorve and Pernilla Wikström and Sara Strandberg and Joakim Jonsson},
  year = {2026},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-026-15906-6},
  url = {https://doi.org/10.1186/s12885-026-15906-6}
}

RIS

TY  - JOUR
TI  - Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095
AU  - Karin Söderkvist
AU  - Maira Zia
AU  - Adalsteinn Gunnlaugsson
AU  - Andreas Josefsson
AU  - Bjørg Aksnessæther
AU  - Chunde Li
AU  - Camilla Thellenberg-Karlsson
AU  - Daniel Alm
AU  - David Kudrén
AU  - Erik Lundin
AU  - Gabriel Moise
AU  - Jenny Kahlmeter Brandell
AU  - Jon Kindblom
AU  - Kirsten Björnlinger
AU  - Kristin Karlsson
AU  - Katrine Riklund
AU  - Martina Westin
AU  - Mattias Hedman
AU  - Natalie Skorve
AU  - Pernilla Wikström
AU  - Sara Strandberg
AU  - Joakim Jonsson
PY  - 2026
JO  - BMC Cancer
DO  - 10.1186/s12885-026-15906-6
UR  - https://doi.org/10.1186/s12885-026-15906-6
ER  -

APA

Söderkvist, K., Zia, M., Gunnlaugsson, A., Josefsson, A., Aksnessæther, B., Li, C., Thellenberg-Karlsson, C., Alm, D., Kudrén, D., Lundin, E., Moise, G., Brandell, J. K., Kindblom, J., Björnlinger, K., Karlsson, K., Riklund, K., Westin, M., Hedman, M., Skorve, N., Wikström, P., Strandberg, S., & Jonsson, J. (2026). Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095. BMC Cancer. https://doi.org/10.1186/s12885-026-15906-6

Source records

crossref · retrieved 2026-09-26T18:22:47.396Z